Syrma SGS Technology Ltd

- The company does not currently require any equity raising over the next 2-3 years. - They have sufficient cash from internal accruals and unspent IPO proceeds (~Rs. 700 crore) to fund acquisitions and organic growth. - Recent acquisition and planned capex are being funded through this cash and internal accruals. - Debt as of June end stands at approximately Rs. 380 crore (term loan Rs. 90 crore, working capital loan Rs. 290 crore). - No immediate plans for fresh fundraising via equity or significant new debt; focus is on consolidating current acquisitions and organic growth. - Management remains open to scouting acquisition opportunities but plans to fund them through existing resources before considering raising new capital.

- Planned capex of Rs. 200-250 crore in FY24 and approximately Rs. 150 crore in FY25, totaling around Rs. 400 crore over two years for organic growth and capacity expansion. - Acquisition-related capex minor, around Rs. 5-10 crore to grow acquired business; acquisition capacity utilization currently ~40%, enabling revenue doubling without significant capex. - Land acquisition for new manufacturing campuses: 16-acre plot in Krishnagiri (Hosur) and 6-acre facility in Chennai, aiming to double production space from 8.5 lakh to 1.5 million sq. ft. over time. - Focus on shifting from standalone factories to campus-based manufacturing hubs to support longer-term growth beyond FY25. - Existing capex partially funded by Rs. 700 crore of unspent IPO proceeds and internal accruals; no immediate equity raising planned. - Acquisition payments include Rs. 28 crore milestone-based payouts tied to profitability over 2-2.5 years.

- The company is confident of exceeding a Rs. 200 crore per month revenue run-rate by the end of the current year, building on historical trends (Page 18). - Export revenues are expected to see a significant leg up, especially driven by new contracts in the utility metering (industrial) sector, currently constituting 25-30% of quarterly exports (Page 12). - Healthcare business, despite recent declines, remains a focus, with potential for growth as it forms part of the ODM segment (Page 22). - New verticals such as railways and medical devices are strategic growth areas intended to diversify revenue streams over 3-5 years, aiming to reduce reliance on automotive and consumer segments (Page 19). - The recently acquired medical devices business has shown 80%+ CAGR, and while conservative growth estimates are 20-35%, any growth beyond this would be beneficial (Page 9). - Overall guidance remains bullish, targeting growth greater than the industry average with maintained EBITDA margins (Page 6).

- Syrma SGS expects to maintain growth higher than the industry average, with Q1 showing 59% YoY revenue growth and strong order book of ~Rs. 3,500 crore. - The recently acquired medical devices business is expected to grow conservatively at 20%-35% over the next 2-3 years, with potential for phenomenal growth if actuals exceed forecast. - EBITDA margin accretion from acquisition is estimated at 1% to 1.5% on full consolidation. - Gross margins are anticipated around 23%-26%, with opportunities to improve if product mix or export share increases. - Operating expenses may initially rise but are expected to normalize as revenue grows, supporting sustainable EBITDA margins in double digits. - Management reaffirms being on track with guidance and optimistic for new business pipelines and overall earnings growth in FY24-FY26.

- Total order book as of June 30, 2023: Approximately Rs. 3,500 crore. - Expected revenue execution from order book in next 12 months: Rs. 2,200 to Rs. 2,300 crore. - Order book composition: Spread across electric mobility, combustion, industrial, consumer sectors (25%-40% each). - Export order book strengthened, with significant growth expected in the railways segment (though starting from a small base). - New orders in the recent quarter: About Rs. 1,100 crore. - New order intake generally stable unless disruptions occur.